Pharma MES 1440 V0a
Webinar

Evaluating a Pharma MES Business Case

15 April, 2:00 - 2:45 pm CEST

Attend the webinar

Need to get your MES project approved?

Very often the argument to refuse an MES project is that there is no business case for MES. Additionally, there are always competing initiatives for spending corporate budgets and reasons to ignore the need for digitization in manufacturing operations.

Does that sound familiar to you?

With this webinar we will show you how to prepare a business case for MES in pharmaceutical and biopharmaceutical production and justify the investment for an MES.

A simple set of steps helps to address objections to MES. It is based on a solid business case mapped to the business needs of the organization. We will discuss a systematic assessment of potential benefits when transitioning from paper-based manufacturing to a digitally operated production. The business case estimation is structured into several areas where the use of an MES can lead to substantial improvements and supports the calculation of a business case of MES.

It works for green field, brown field and upgrade projects.

During the webinar, we will walk you through:

  • How to address objections to MES
  • A systematic assessment of potential benefits of digitalized manufacturing
  • A structured method how to estimate the business

Our presenter is: 

Thomas Halfmann, Global Head Production IT Life Sciences, NNIT

Contact
ACSP

Annette Casper

Marketing Manager for Life Sciences